Biol Reprod Lalor Postdoctoral Fellowships -- Application Deadline January 15, 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print July 13, 2005.
Biol Reprod 2005, 10.1095/biolreprod.105.040980
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
73/5/951    most recent
biolreprod.105.040980v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukai, M.
Right arrow Articles by Cooke, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukai, M.
Right arrow Articles by Cooke, P. S.
Agricola
Right arrow Articles by Mukai, M.
Right arrow Articles by Cooke, P. S.
BIOLOGY OF REPRODUCTION 73, 951–958 (2005)
DOI: 10.1095/biolreprod.105.040980
© 2005 by the Society for the Study of Reproduction, Inc.

Altered Prostatic Epithelial Proliferation and Apoptosis, Prostatic Development, and Serum Testosterone in Mice Lacking Cyclin-Dependent Kinase Inhibitors1

Motoko Mukai 3, Qiang Dong 4, Matthew P. Hardy 4, Hiroaki Kiyokawa 5, Richard E. Peterson 6, and Paul S. Cooke 2, 3

Department of Veterinary Biosciences,3 University of Illinois, Urbana, Illinois 61802 Population Council and Rockefeller University,4 New York, New York 10021 Department of Molecular Genetics,5 College of Medicine, University of Illinois, Chicago, Illinois 60607 School of Pharmacy,6 University of Wisconsin, Madison, Wisconsin 53705

Normal prostatic development and some prostatic diseases involve altered expression of the cell-cycle regulators p27 and p21 (also known as CDKN1B and CDKN1A, respectively). To determine the role of these proteins in the prostate, we examined prostatic phenotype and development in mice lacking p27 and/or p21. In p27-knockout (p27KO) mice, epithelial proliferation was increased 2- and 3.8-fold in the ventral and dorsolateral prostate, respectively, versus wild-type (WT) mice, although prostatic weights were not different. Epithelial apoptosis was increased in p27KO mice and may account for the lack of a concurrent increase in weight. Testosterone deficiency observed in this group was not the cause of this increase, because vehicle- and testosterone-treated p27KO mice had similar percentages of apoptotic cells. Also observed was a trend toward a decreased functional epithelial cytodifferentiation, indicating a potential role of p27 in this process. Conversely, dorsolateral prostate and seminal vesicle (SV) of p21-knockout (p21KO) mice, and all prostatic lobes and SV of p21/p27 double-knockout mice, weighed significantly less compared to the WT mice, and their epithelial proliferation was normal. Decreased testosterone concentrations may contribute to the decreased prostatic weights. However, other factors may be involved, because testosterone replacement only partially restored prostatic weights. We conclude that loss of p27 increases prostatic epithelial proliferation and alters differentiation but does not result in prostatic hyperplasia because of increased epithelial cell loss. The p21KO mice showed phenotypes distinctly different from those of p27KO mice, suggesting nonredundant roles of p21 and p27 in prostatic development. Loss of p27 or of both p21 and p27 results in serum testosterone deficiency, complicating analysis of the prostatic effects of these cell-cycle regulators.

apoptosis, male reproductive tract, prostate, testosterone


1 Supported by NIH grants AGO24387 (to P.S.C.), HD3005 (to H.K.), HD32588 (to M.P.H), ES01332 (to R.E.P.), and the Thanis A. Field Endowment. M.M. was an Environmental Toxicology Scholar at the University of Illinois and was also supported by an Eli Lilly Predoctoral Fellowship (Eli Lilly Co., Indianapolis, IN). The present investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR16515 from the National Center for Research Resources, National Institutes of Health.

2 Correspondence: Paul S. Cooke, Department of Veterinary Biosciences, University of Illinois at Urbana-Champaign, 2001 S. Lincoln Ave, Urbana, IL 61802. FAX: 217 244 1652; p-cooke{at}uiuc.edu







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for the Study of Reproduction.